Hologic (HOLX) closed at $61.82 in the latest ... this stock is poised for big gains. Of course, all our elite picks aren’t winners but this one could far surpass earlier Zacks’ Stocks Set ...

Hologic’sfirst-quarter revenues of $1.02 billion ... this stock is poised for big gains. Of course, all our elite picks aren’t winners but this one could far surpass earlier Zacks’ Stocks ...

The No. 4-ranked Jessica Pegula converted five of seven break points and needed just over an hour to reach the Indian Wells ...

World No. 1 Aryna Sabalenka and No. 11 Mirra Andreeva will compete for a third time this season, with the winner walking away ...

Q4 2024 Earnings Call Transcript March 6, 2025 Profound Medical Corp. beats earnings expectations. Reported EPS is $-0.2, ...

That organization was recently acquired by Hologic, and the list goes on of ... is prototypical of anyone in the cancer arena, which of course we are, which is to focus on the top 50 cancer ...

Identification of acute HIV-1 infection by hologic aptima HIV-1 RNA qualitative assay ... Features of the clinical course of invasive Candidiasis in HIV-infected patients. Ann Rom Soc Cell Biol.

Hologic (HOLX) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term.

Last week, Hologic HOLX earned two key regulatory approvals. The company’s Affirm Contrast Biopsy software has earned the CE Mark, having previously been cleared by the FDA in October 2020.

Hologic stock opened at $62.30 on Monday. The company has a 50-day simple moving average of $68.77 and a 200-day simple moving average of $75.64. The firm has a market capitalization of $13.98 ...